Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use? (Q38323055)

2 September 2017

1 reference

title

Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use? (English)

1 reference

Johanna Sofia Margareta Mattsson

2 September 2017

0 references

1 reference

series ordinal

3

object named as

Johanna Sofia Margareta Mattsson

1 reference

PubMed ID

25599124

Cecilia Lindskog Bergström

2 September 2017

series ordinal

1

object named as

Cecilia Lindskog

1 reference

2 September 2017

2

Karolina Edlund

1 reference

2 September 2017

Patrick Micke

4

1 reference

2 September 2017

19 January 2015

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

2 September 2017

1 reference

2 September 2017

15

1 reference

2 September 2017

471-490

1 reference

2 September 2017

4

1 reference

2 September 2017

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Characterizing the cancer genome in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Comprehensive genomic characterization of squamous cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Management of non-small-cell lung cancer: recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The significance of epigenetic alterations in lung carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Prognostic gene expression signature for squamous cell carcinoma of lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Prognostic immune markers in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Prognostic relevance of cancer-associated fibroblasts in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Clinical impact of ki-67 labeling index in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

New biomarkers for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

21 January 2018

New roles of cyclin D1.

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The role of cyclin D1 expression and patient's survival in non-small-cell lung cancer: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Prognostic role of epidermal growth factor receptor in stage III nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

ASCO-CAP guidelines for breast predictive factor testing: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Discovery and saturation analysis of cancer genes across 21 tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The co-expression of ERβ2 and IL-12Rβ2 is better prognostic factor in non-small-cell lung cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

New modalities of cancer treatment for NSCLC: focus on immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Wnt1 overexpression promotes tumour progression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Cancer stem cell-related marker expression in lung adenocarcinoma and relevance of histologic subtypes based on IASLC/ATS/ERS classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

CNS stem cells express a new class of intermediate filament protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Cancer stem cells: A contentious hypothesis now moving forward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Associations between TS, TTF-1, FR-α, FPGS, and overall survival in patients with advanced non-small-cell lung cancer receiving pemetrexed plus carboplatin or gemcitabine plus carboplatin as first-line chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Expression of NDRG2 in human lung cancer and its correlation with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

LAT1 expression in non-small-cell lung carcinomas: analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

DENR-MCT-1 promotes translation re-initiation downstream of uORFs to control tissue growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Antibody validation of immunohistochemistry for biomarker discovery: recommendations of a consortium of academic and pharmaceutical based histopathology researchers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Garbage in, garbage out: a critical evaluation of strategies used for validation of immunohistochemical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

An open letter to our readers on the use of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

NCBI GEO: archive for functional genomics data sets--update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

ArrayExpress update--trends in database growth and links to data analysis tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Antibodypedia, a portal for sharing antibody and antigen validation data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

C-erbB-2 immunostaining: problems with interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Virtual microscopy as an enabler of automated/quantitative assessment of protein expression in TMAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

CAS proteins in normal and pathological cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

p130Cas: a key signalling node in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Role of claudin interactions in airway tight junctional permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Claudins in lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Translational control in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Dissecting eIF4E action in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Eukaryotic initiation factor-4E and cyclin D1 expression associated with patient survival in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

EZH2, an epigenetic driver of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Farletuzumab in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

FOX(M1) news--it is cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

CIP2A is associated with human breast cancer aggressivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

MCM proteins: evolution, properties, and role in DNA replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Geminin expression in small lung adenocarcinomas: implication of prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

AEG-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Steroid receptor coactivator-3 as a potential molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

NDRG2: a Myc-repressed gene involved in cancer and cell stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Critical roles of T-LAK cell-originated protein kinase in cytokinesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Overexpression of T-LAK cell-originated protein kinase predicts poor prognosis in patients with stage I lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Proto-oncogene Wip1, a member of a new family of proliferative genes in NSCLC and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

SIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Solute carrier transporters as targets for drug delivery and pharmacological intervention for chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

p62/SQSTM1/A170: physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

WNT signalling pathways as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Wnt signaling pathway in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2015.1002772

10.1586/14737159.2015.1002772

21 January 2018

Identifiers

DOI

1 reference

release_pp5ys4px4rbqvjwkiabezcplfm

2 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pp5ys4px4rbqvjwkiabezcplfm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

25599124

1 reference

PubMed ID

25599124